USP18 negatively regulates the ISGylation of FOXO3a, a protein that suppresses TGFβ1-induced fibronectin expression in human lung fibroblasts, suggesting that USP18 could be a potential target for treating IPF 47. The gene discussed is USP18; the disease is idiopathic pulmonary fibrosis.